Articles

Stryker, Trevo Retriever, stent thrombectomy, trial, Netherlands

In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a...

Volcano, Philips, acquisition, FFR, IVUS

The purchase will enable Philips to further expand its advanced imaging capabilities of its angiography suite. Volcano is a leader in intravascular ultrasound (IVUS) and fractional flow reserve (...

Doctors at St. Joseph’s Children’s Hospital of Tampa implanted a Melody transcatheter pulmonary valve in a 13-year-old patient in October, marking the 50th time the hospital has given the device...

near-infrared spectroscopy, NIRS, heart attack, stroke, Infraredx, TVC

A study published in the Journal of the American College of Cardiology (JACC) shows intravascular near-infrared spectroscopy (NIRS) can identify lipid core-containing plaques,...

DAPT study

Patients who took dual antiplatelet therapy medications beyond the standard 12 months after coronary stent placement were significantly less likely to develop blood clots within their stents or to...

VIVA, VIVA Physicians, Peripheral, Carotid Artery Device, clinical trial results

Viva Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announce clinical trial results and other new happenings at Viva '14, hosted in Las Vegas,...

Shockwave, lithoplasty, lithotripsy

Shockwave Medical announced positive clinical results from Disrupt PAD, a single-arm multicenter study evaluating the safety and utility of Lithoplasty balloon catheters for the treatment of...

For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral ...

Samsung Tablet-based Ultrasound, PT60A, Emergency Services

Samsung Electronics America Inc. announced the preliminary results of a groundbreaking trial into the use of tablet-based ultrasound in emergency services vehicles.

Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S. FDA to initiate the U.S. arm of its Tiara-I Early Feasibility Trial for the company's Tiara...